FLASH放疗在小鼠乳腺癌模型中保护肝功能并维持代谢稳态
该临床前研究将4T1乳腺癌小鼠随机给予单次20 Gy的FLASH-RT(625 Gy/s)或CONV-RT(0.54 Gy/s)6 MeV电子束照射,两种模式肿瘤控制等效,但FLASH-RT肝损伤标志物更低、氧化应激与炎症更轻,并维持肝脏代谢稳态。
要点
- FLASH-RT与CONV-RT肿瘤生长延迟等效。
- FLASH-RT血清ALT/ALP更低,MDA更低、GSH-PX更高。
- FLASH-RT减轻肝纤维化信号与免疫炎症浸润。
核心结论
- FLASH-RT通过保护肝结构完整性、减轻氧化炎症信号并维持代谢稳定,实现显著肝脏保护。
- FLASH-RT可能通过解耦抗肿瘤疗效与肝脏附带毒性来拓宽治疗窗。
研究设计与样本
- 临床前实验研究,雌性BALB/c小鼠接种同系4T1乳腺癌后随机分组。
- 单次20 Gy,FLASH-RT剂量率625 Gy/s,CONV-RT剂量率0.54 Gy/s,6 MeV电子束。
- 观察肿瘤动力学与全身毒性14天,并评估肝脏组织学、免疫组化、氧化应激标志物、血清生化及肝脏非靶向UPLC-MS/MS代谢组学。
主要发现
- 两种模式均实现等效的肿瘤生长延迟。
- FLASH-RT仅引起短暂体重下降并快速恢复,肝损伤标志物较CONV-RT减少。
- FLASH-RT preserved hepatic architecture并减弱早期促纤维化信号,α-SMA与Nestin表达较CONV-RT降低。
- FLASH组血清ALT/ALP显著更低,氧化应激减轻(MDA更低、GSH-PX更高)。
- FLASH-RT减轻免疫介导炎症,CD8+ T细胞与F4/80+巨噬细胞浸润减少,并防止CONV-RT后出现的显著脂质与胆碱代谢紊乱。
临床怎么用
- 在乳腺癌放疗涉及肝脏受照时,FLASH-RT可能提供肝保护优势而不牺牲肿瘤控制。
- 血清ALT/ALP、MDA、GSH-PX及肝组织α-SMA、Nestin、CD8+ T与F4/80+浸润可作为临床前肝损伤评估参考。
局限性
- 研究为小鼠临床前实验,样本量、随访时长及具体统计值未在摘要中报告。
- 结论需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiotherapy (RT) for treating breast cancer can result in incidental dose deposition to the liver, leading to functional impairment. FLASH radiotherapy (FLASH-RT), delivered at ultra-high dose rates (UHDR), has demonstrated remarkable normal tissue sparing. We investigated the hepatoprotective effects and metabolic alterations associated with FLASH-RT and conventional radiotherapy (CONV-RT) in a preclinical breast cancer model. METHODS: Female BALB/c mice bearing syngeneic 4T1 breast tumors were randomized to receive a single 20 Gy fraction of either FLASH-RT (625 Gy/s) or CONV-RT (0.54 Gy/s) using a 6 MeV electron beam. Tumor kinetics and systemic toxicity were monitored for 14 days. Hepatic integrity was assessed via histology, immunohistochemistry, oxidative-stress markers, serum biochemical assays, and non-targeted UPLC-MS/MS metabolomics of liver tissue. RESULTS: Both modalities achieved isoeffective tumor growth delay. However, FLASH-RT induced only transient body-weight reduction followed by rapid recovery, and was associated with reduced hepatic injury markers compared with CONV-RT. Histopathological analysis revealed that FLASH-RT preserved hepatic architecture and attenuated early pro-fibrotic signaling, as reflected by reduced α-SMA and Nestin expression compared with CONV-RT. FLASH-treated mice exhibited significantly lower serum ALT/ALP levels and reduced oxidative stress (lower MDA levels and higher GSH-PX levels). Furthermore, FLASH-RT attenuated immune-mediated inflammation, as evidenced by diminished infiltration of CD8 + T cells and F4/80 + macrophages. Metabolomic profiling demonstrated that FLASH-RT preserved hepatic metabolic homeostasis, preventing the profound lipid and choline metabolism disruptions observed following CONV-RT. CONCLUSIONS: FLASH-RT was associated with substantial hepatic sparing by preserving structural integrity, attenuating oxidative-inflammatory signaling, and maintaining metabolic stability. These findings suggest that FLASH-RT may help expand the therapeutic window by uncoupling antitumor efficacy from collateral hepatic toxicity.
引用
- Lu X, Xie D, Cui L, et al. FLASH radiotherapy preserves hepatic function and maintains metabolic homeostasis in a murine breast cancer model: an experimental preclinical study. Radiat Oncol. 2026. PMID: 42321761. doi:10.1186/s13014-026-02878-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。